Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

News Daily News

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

L.A. McKeown

October 14, 2025

Presentation TCT 2024

TCT 1289: Challenged Case of Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation Using Self-Expanding Valve

Presenter: Wenzhi Pan

October 28, 2024

Presentation TCT 2024

TCT 1541: Transcatheter Aortic Valve Replacement for Severe Aortic Valve Insufficiency in a 39-Year-Old Female With Complex Congenital Heart Disease and Prohibitive Surgical Risk: A Case Report

Presenter: Marjolein Le

October 28, 2024

Presentation TCT 2024

TCT 1393: One-Stop Transcatheter Therapy for a Combined Valvular Disease: Several Pure Aortic Regurgitation + Degenerated Mitral Regurgitation

Presenter: Junjie Zhang

October 28, 2024

Presentation TCT 2024

TCT 1207: Implantation of a Self-Expanding TAVR Prosthesis in a Patient With Pure AR: Hostile Horizontal Ascending Aorta and Aortic Stent-Graft

Presenter: Felix Meincke

October 28, 2024

Presentation TCT 2024

Options for Transcatheter Treatment of Aortic Regurgitation Depending on Regional Resources

Presenter: Breno Falcao

October 28, 2024

Presentation TCT 2024

TCT 876: Noncoronary Sinus Pivot Implantation Strategy for Transcatheter Aortic Valve Replacement With Self-Expanding Valve in Pure Aortic Regurgitation

Presenter: Wenzhi Pan

October 27, 2024

Presentation TCT 2024

TCT 871: An Update on Transcatheter Aortic Valve Replacement in Pure Aortic Regurgitation With Left Ventricular Assist Device

Presenter: Chong Bin Lee

October 27, 2024

Presentation TCT 2024

TCT 875: A Multicenter Prospective Clinical Study on TAVI With the J-Valve THV for Native Pure Aortic Regurgitation: Five-Year Follow-up Outcome

Presenter: Yingqiang Guo

October 27, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

Presentation NY Valves 2024

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Presenter: Sahar Samimi

June 07, 2024

Presentation NY Valves 2024

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

Presenter: Matti Adam

June 07, 2024

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Presentation NY Valves 2024

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Presenter: Raj Makkar

June 07, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Implantation for Pure Aortic Valve Regurgitation? Insights From the France-TAVI Nationwide French Registry: The PAVR Study

Presenter: Robin Le Ruz

June 07, 2024

Presentation NY Valves 2024

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Presenter: Jonathan Curio

June 06, 2024

Presentation NY Valves 2024

Transcatheter Heart Valve for Treatment of Pure Native AR With Minimal AV Calcium, Large Annulus and Large Aorta

Presenter: Hasan Jilaihawi

June 06, 2024

Presentation NY Valves 2024

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

Presenter: Arianna Favela

June 06, 2024

Presentation NY Valves 2024

Current Status of Dedicated Valve Platforms for Pure Aortic Regurgitation and Update on Trial Data

Presenter: Torsten P. Vahl

June 05, 2024

Presentation NY Valves 2024

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

Presenter: Raj Makkar

June 05, 2024

Advertisement

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

TCT 1289: Challenged Case of Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation Using Self-Expanding Valve

TCT 1541: Transcatheter Aortic Valve Replacement for Severe Aortic Valve Insufficiency in a 39-Year-Old Female With Complex Congenital Heart Disease and Prohibitive Surgical Risk: A Case Report

TCT 1393: One-Stop Transcatheter Therapy for a Combined Valvular Disease: Several Pure Aortic Regurgitation + Degenerated Mitral Regurgitation

TCT 1207: Implantation of a Self-Expanding TAVR Prosthesis in a Patient With Pure AR: Hostile Horizontal Ascending Aorta and Aortic Stent-Graft

Options for Transcatheter Treatment of Aortic Regurgitation Depending on Regional Resources

TCT 876: Noncoronary Sinus Pivot Implantation Strategy for Transcatheter Aortic Valve Replacement With Self-Expanding Valve in Pure Aortic Regurgitation

TCT 871: An Update on Transcatheter Aortic Valve Replacement in Pure Aortic Regurgitation With Left Ventricular Assist Device

TCT 875: A Multicenter Prospective Clinical Study on TAVI With the J-Valve THV for Native Pure Aortic Regurgitation: Five-Year Follow-up Outcome

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Transcatheter Aortic Valve Implantation for Pure Aortic Valve Regurgitation? Insights From the France-TAVI Nationwide French Registry: The PAVR Study

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Transcatheter Heart Valve for Treatment of Pure Native AR With Minimal AV Calcium, Large Annulus and Large Aorta

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

Current Status of Dedicated Valve Platforms for Pure Aortic Regurgitation and Update on Trial Data

Lessons From Off Label TAVR Use in Pure AR – Tips & Tricks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content